TGFβ2 and TGFβ3 are potent survival factors for midbrain dopaminergic neurons

[1]  W. Snider,et al.  Functions of the neurotrophins during nervous system development: What the knockouts are teaching us , 1994, Cell.

[2]  L. Olson,et al.  Glial Cell Line-Derived Neurotrophic Factor Is Expressed in the Developing but Not Adult Striatum and Stimulates Developing Dopamine Neurons in Vivo , 1993, Experimental Neurology.

[3]  I. Black,et al.  Regional and Cell-Specific Expression of GDNF in Rat Brain , 1993, Experimental Neurology.

[4]  M. Barbacid,et al.  Targeted disruption of the trkB neurotrophin receptor gene results in nervous system lesions and neonatal death , 1993, Cell.

[5]  P. Seeman,et al.  Dopamine D4 receptors elevated in schizophrenia , 1993, Nature.

[6]  A. Davies,et al.  Different neurotrophins are expressed and act in a developmental sequence to promote the survival of embryonic sensory neurons. , 1993, Development.

[7]  J. Lile,et al.  GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. , 1993, Science.

[8]  J. Rogers.  Immunohistochemical markers in rat brain: colocalization of calretinin and calbindin-D28k with tyrosine hydroxylase , 1992, Brain Research.

[9]  A. Davies,et al.  Neurotrophic factors promote the maturation of developing sensory neurons before they become dependent on these factors for survival , 1992, Neuron.

[10]  T. Soderling,et al.  Serine/threonine protein kinases , 1992, Current Opinion in Neurobiology.

[11]  H. Moses,et al.  Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development , 1991, The Journal of cell biology.

[12]  D. Goeddel,et al.  Neurotrophin-5: A novel neurotrophic factor that activates trk and trkB , 1991, Neuron.

[13]  J. Engele,et al.  The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia [published erratum appears in J Neurosci 1992 Mar;12(3):685] , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[14]  D. Casper,et al.  EGF enhances the survival of dopamine neurons in rat embryonic mesencephalon primary cell culture , 1991, Journal of neuroscience research.

[15]  M. Sporn,et al.  Localization and actions of transforming growth factor-beta s in the embryonic nervous system. , 1991, Development.

[16]  G. Yancopoulos,et al.  BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra , 1991, Nature.

[17]  F. Hefti,et al.  Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[18]  H. Phillips,et al.  Widespread expression of BDNF but not NT3 by target areas of basal forebrain cholinergic neurons. , 1990, Science.

[19]  M. Dickinson,et al.  In situ hybridization analysis of TGF beta 3 RNA expression during mouse development: comparative studies with TGF beta 1 and beta 2. , 1990, Development.

[20]  J. Schwaber,et al.  Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and II , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[21]  R. Spealman,et al.  Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. , 1989, The Journal of pharmacology and experimental therapeutics.

[22]  R. Derynck,et al.  A new type of transforming growth factor‐beta, TGF‐beta 3. , 1988, The EMBO journal.

[23]  P. ten Dijke,et al.  Identification of another member of the transforming growth factor type beta gene family. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[24]  B. Haendler,et al.  Complementary DNA for human glioblastoma‐derived T cell suppressor factor, a novel member of the transforming growth factor‐beta gene family. , 1987, The EMBO journal.

[25]  M. Kuhar,et al.  Cocaine receptors on dopamine transporters are related to self-administration of cocaine. , 1987, Science.

[26]  K. Frei,et al.  T cell suppressor factor from human glioblastoma cells is a 12.5‐kd protein closely related to transforming growth factor‐beta. , 1987, The EMBO journal.

[27]  J. McPherson,et al.  Cartilage-inducing factor-A. Apparent identity to transforming growth factor-beta. , 1986, The Journal of biological chemistry.

[28]  Anita B. Roberts,et al.  Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells , 1985, Nature.

[29]  D. Reis,et al.  Light‐microscopic immunocytochemical localization of tyrosine hydroxylase in prenatal rat brain. II. Late ontogeny , 1981, The Journal of comparative neurology.

[30]  P. Campochiaro,et al.  ONTOGENESIS OF DOPAMINERGIC‐CHOLINERGIC INTERACTIONS IN THE RAT STRIATUM: A NEUROCHEMICAL STUDY , 1976, Journal of neurochemistry.

[31]  P. Seeman,et al.  Antipsychotic drug doses and neuroleptic/dopamine receptors , 1976, Nature.

[32]  P. Seeman,et al.  Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. , 1975, Science.

[33]  S H Snyder,et al.  Drugs, neurotransmitters, and schizophrenia. , 1974, Science.

[34]  H. Phillips,et al.  Neurotrophic‐4/5 is a survival factor for embryonic midbrain dopaminergic neurons in enriched cultures , 1994 .

[35]  M. Sporn,et al.  Physiological Actions and Clinical Applications of Transforming Growth Factor-β (TGF-β) , 1993 .

[36]  M. Sporn,et al.  Complementary deoxyribonucleic acid cloning of a novel transforming growth factor-beta messenger ribonucleic acid from chick embryo chondrocytes. , 1988, Molecular endocrinology.

[37]  F E Bloom,et al.  Central catecholamine neuron systems: anatomy and physiology of the dopamine systems. , 1978, Annual review of neuroscience.